This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopae [2025/03/10 10:16] – [Biological function] rkoebnik | bacteria:t3e:xopae [2025/07/07 12:42] (current) – [References] rkoebnik | ||
---|---|---|---|
Line 2: | Line 2: | ||
Author: [[https:// | Author: [[https:// | ||
- | Internal | + | Internal |
Expert reviewer: [[https:// | Expert reviewer: [[https:// | ||
Line 10: | Line 10: | ||
GenBank ID: [[https:// | GenBank ID: [[https:// | ||
RefSeq ID: [[https:// | RefSeq ID: [[https:// | ||
- | Synonyms: XopAE was also referred to as HpaF (Kim //et al.//, 2003; Sugio //et al.//, 2005). In //Xcv// strain 85-10, the gene is bipartite and the two parts were first coined //hpaF// and //hpaG// (Noël //et al.//, 2002). Be careful: //hpaG// was also used in other Xanthomonas to designate the homolog of //hpa1// (//X. campestris//, | + | Synonyms: XopAE was also referred to as HpaF (Kim //et al.//, 2003; Sugio //et al.//, 2005). In //Xee// strain 85-10, the gene is bipartite and the two parts were first coined //hpaF// and //hpaG// (Noël //et al.//, 2002). Be careful: //hpaG// was also used in other //Xanthomonas// to designate the homolog of //hpa1// (//X. campestris//, |
- | 3D structure: Most XopAE possesses a N-terminal leucine-rich repeat (LRR) domain and a C-terminal XL box motif with an E3 ubiquitin ligase fold, based on homology modelling (Popov //et al//., 2018). Predicted fold of XopAE C terminus is similar to that of XopL (Popov //et al//., 2018). | + | 3D structure: Most XopAE possesses a N-terminal leucine-rich repeat (LRR) domain and a C-terminal XL box motif with an E3 ubiquitin ligase fold, based on homology modelling (Popov //et al.//., 2018). Predicted fold of XopAE C terminus is similar to that of XopL (Popov //et al.//, 2018). |
===== The locus ===== | ===== The locus ===== | ||
Line 21: | Line 21: | ||
XopAE was discovered by studying // | XopAE was discovered by studying // | ||
+ | |||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
XopAE< | XopAE< | ||
+ | |||
=== Regulation === | === Regulation === | ||
In //Xee// strain 85-10, //xopAE// < | In //Xee// strain 85-10, //xopAE// < | ||
+ | |||
=== Phenotypes === | === Phenotypes === | ||
XopAE< | XopAE< | ||
+ | |||
=== Localization === | === Localization === | ||
XopAE< | XopAE< | ||
+ | |||
=== Enzymatic function === | === Enzymatic function === | ||
XopAE< | XopAE< | ||
+ | |||
=== Interaction partners === | === Interaction partners === | ||
Line 52: | Line 58: | ||
===== References ===== | ===== References ===== | ||
- | Gomez De la Cruz D, Castillo DA, Trujillo B CA, Medina CA, Hurtado V, Gil J, Padmanabhan M, Restrepo S, Dinesh-Kumar SP, Germain H, Lopez C, Bernal A (2025). XopAE effector from Xanthomonas phaseoli pv. manihotis targets HSP20-like p23 cochaperone to suppress plant basal immunity. Mol. Plant Microbe Interact., in press. DOI: [[https:// | + | Gomez De la Cruz D, Castillo DA, Trujillo B CA, Medina CA, Hurtado V, Gil J, Padmanabhan M, Restrepo S, Dinesh-Kumar SP, Germain H, Lopez C, Bernal A (2025). XopAE effector from //Xanthomonas phaseoli |
+ | 38: 365-375 | ||
Kim JG, Park BK, Yoo CH, Jeon E, Oh J, Hwang I (2003). Characterization of the // | Kim JG, Park BK, Yoo CH, Jeon E, Oh J, Hwang I (2003). Characterization of the // |